Key words: Esophageal cancer, Neoadjuvant therapy, Squamous cell carcinoma
Peritoneal dissemination, Ascites, Tumor microenvironment, Gastric cancer, Mesenchymal cells, Mesothelial cells, MDSCs, Tenascin-C, extracellular matrix, Mass cytometry